Trials / Conditions / Astrocytoma, IDH-Mutant, Grade 4
Astrocytoma, IDH-Mutant, Grade 4
5 registered clinical trials studyying Astrocytoma, IDH-Mutant, Grade 4 — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas NCT07468136 | Mayo Clinic | Phase 1 / Phase 2 |
| Enrolling By Invitation | Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma NCT06896110 | Andrew P. Groves | Phase 1 |
| Recruiting | Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques NCT06623565 | Amsterdam UMC, location VUmc | N/A |
| Recruiting | SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) NCT05303519 | Nuvation Bio Inc. | Phase 3 |
| Active Not Recruiting | A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With NCT04145115 | National Cancer Institute (NCI) | Phase 2 |